These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 12655721)

  • 61. High local concentrations and effects on differentiation implicate interleukin-6 as a paracrine regulator.
    Sopasakis VR; Sandqvist M; Gustafson B; Hammarstedt A; Schmelz M; Yang X; Jansson PA; Smith U
    Obes Res; 2004 Mar; 12(3):454-60. PubMed ID: 15044662
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Effects of pioglitazone on metabolic parameters, body fat distribution, and serum adiponectin levels in Japanese male patients with type 2 diabetes.
    Hirose H; Kawai T; Yamamoto Y; Taniyama M; Tomita M; Matsubara K; Okazaki Y; Ishii T; Oguma Y; Takei I; Saruta T
    Metabolism; 2002 Mar; 51(3):314-7. PubMed ID: 11887166
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Decreased serum levels of adiponectin are a risk factor for the progression to type 2 diabetes in the Japanese Population: the Funagata study.
    Daimon M; Oizumi T; Saitoh T; Kameda W; Hirata A; Yamaguchi H; Ohnuma H; Igarashi M; Tominaga M; Kato T;
    Diabetes Care; 2003 Jul; 26(7):2015-20. PubMed ID: 12832305
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Hypoadiponectinemia is an independent risk factor for hypertension.
    Iwashima Y; Katsuya T; Ishikawa K; Ouchi N; Ohishi M; Sugimoto K; Fu Y; Motone M; Yamamoto K; Matsuo A; Ohashi K; Kihara S; Funahashi T; Rakugi H; Matsuzawa Y; Ogihara T
    Hypertension; 2004 Jun; 43(6):1318-23. PubMed ID: 15123570
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Insulin-sensitizing agents: metformin and thiazolidinedione derivatives].
    Satoh J
    Nihon Rinsho; 2003 Jul; 61(7):1224-9. PubMed ID: 12877089
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Trans-10,cis-12 CLA increases liver and decreases adipose tissue lipids in mice: possible roles of specific lipid metabolism genes.
    Warren JM; Simon VA; Bartolini G; Erickson KL; Mackey BE; Kelley DS
    Lipids; 2003 May; 38(5):497-504. PubMed ID: 12880104
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Peroxisome proliferator-activated receptor-gamma: a versatile metabolic regulator.
    Rocchi S; Auwerx J
    Ann Med; 1999 Oct; 31(5):342-51. PubMed ID: 10574507
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Searching for type 2 diabetes genes: prospects in pharmacotherapy.
    Sesti G
    Pharmacogenomics J; 2002; 2(1):25-9. PubMed ID: 11990377
    [No Abstract]   [Full Text] [Related]  

  • 69. Single-nucleotide polymorphism haplotypes in the both proximal promoter and exon 3 of the APM1 gene modulate adipocyte-secreted adiponectin hormone levels and contribute to the genetic risk for type 2 diabetes in French Caucasians.
    Vasseur F; Helbecque N; Dina C; Lobbens S; Delannoy V; Gaget S; Boutin P; Vaxillaire M; Leprêtre F; Dupont S; Hara K; Clément K; Bihain B; Kadowaki T; Froguel P
    Hum Mol Genet; 2002 Oct; 11(21):2607-14. PubMed ID: 12354786
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Research advancement of adipocytokine adiponectin].
    Xiao FY; Lu FE
    Sheng Li Ke Xue Jin Zhan; 2003 Oct; 34(4):309-13. PubMed ID: 14992011
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The genetic basis of diabetes mellitus.
    Morwessel NJ
    AACN Clin Issues; 1998 Nov; 9(4):539-54. PubMed ID: 9855864
    [TBL] [Abstract][Full Text] [Related]  

  • 72. [Lipodystrophic diabetes].
    Sakaue H; Kasuga M
    Nihon Rinsho; 2002 Sep; 60 Suppl 9():809-14. PubMed ID: 12387089
    [No Abstract]   [Full Text] [Related]  

  • 73. A Pro12Ala polymorphism in the human peroxisome proliferator-activated receptor-gamma 2 is associated with combined hyperlipidaemia in obesity.
    Swarbrick MM; Chapman CM; McQuillan BM; Hung J; Thompson PL; Beilby JP
    Eur J Endocrinol; 2001 Mar; 144(3):277-82. PubMed ID: 11248748
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Adiponectin: from adipocyte to skeletal muscle].
    Ferré P
    Ann Endocrinol (Paris); 2004 Feb; 65(1 Suppl):S36-43. PubMed ID: 15163922
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Genetics of the metabolic syndrome.
    Groop L
    Br J Nutr; 2000 Mar; 83 Suppl 1():S39-48. PubMed ID: 10889791
    [TBL] [Abstract][Full Text] [Related]  

  • 76. A Val227Ala polymorphism in the peroxisome proliferator activated receptor alpha (PPARalpha) gene is associated with variations in serum lipid levels.
    Yamakawa-Kobayashi K; Ishiguro H; Arinami T; Miyazaki R; Hamaguchi H
    J Med Genet; 2002 Mar; 39(3):189-91. PubMed ID: 11897821
    [No Abstract]   [Full Text] [Related]  

  • 77. Synthetic peroxisome proliferator-activated receptor-gamma agonist, rosiglitazone, increases plasma levels of adiponectin in type 2 diabetic patients.
    Yang WS; Jeng CY; Wu TJ; Tanaka S; Funahashi T; Matsuzawa Y; Wang JP; Chen CL; Tai TY; Chuang LM
    Diabetes Care; 2002 Feb; 25(2):376-80. PubMed ID: 11815513
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Xenobiotic nuclear receptors, new tricks for an old dog.
    Xie W
    Biochim Biophys Acta; 2016 Sep; 1859(9):1071. PubMed ID: 27130698
    [No Abstract]   [Full Text] [Related]  

  • 79. Plasma adiponectin concentrations predict insulin sensitivity of both glucose and lipid metabolism.
    Tschritter O; Fritsche A; Thamer C; Haap M; Shirkavand F; Rahe S; Staiger H; Maerker E; Häring H; Stumvoll M
    Diabetes; 2003 Feb; 52(2):239-43. PubMed ID: 12540592
    [TBL] [Abstract][Full Text] [Related]  

  • 80. [New aspects of adipocytokines].
    Hunabashi T
    Nihon Ronen Igakkai Zasshi; 2003 Sep; 40(5):429-38. PubMed ID: 14579707
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.